Study S002565

Continuous Glucose Monitoring (CGM) in Type 2 Diabetes (T2D) Basal Insulin Users: The Mobile Study (MOBILE)

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT03566693
Acronym: MOBILE
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: NONE
Status: COMPLETED
Enrollment: 176
Start: 2018-07-30
Primary completion: 2021-01-04
Lead sponsor: DexCom, Inc.
Conditions: Diabetes Mellitus, Type 2
Interventions: DEVICE:Dexcom G6 CGM System; DEVICE:Blood glucose meter
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Phase 1: Change in HbA1c [Baseline to Month 8]
Phase 2: Change in CGM time in target range [Month 8 to Month 14]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.